Reports Q3 revenue $5.24M, consensus $4.83M. The company said, “Due to the announced plan to realign resources to support the left-heart access distribution business and exit from the electrophysiology mapping and ablation businesses, the Company will no longer provide financial guidance.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AFIB:
- Acutus Medical Announces Strategic Realignment of Resources and Corporate Restructuring
- Acutus Medical Reports Third Quarter 2023 Financial Results
- Acutus Medical to Announce Third Quarter 2023 Financial Results
- Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue